Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • seqtechno1
    Member
    • May 2017
    • 21

    #1

    pacbio sequel system

    how much do core facilities charge to run the instrument, not per sample or SMRTcell but just to recover the cost of running the device? (electricity, nitrogen, etc.)
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    This is a rare case and I do not think that someone would have any readily available figures. It seems that you want to place your machine in a core lab and operate it yourself. The cost will depend on if you are going to use other facilities such as bench space and lab equipment. I would consider paying space rent and associated costs such as security, electricity, Nitrogen gas, IT infrastructure for transferring and/or storing data (sort of fixed expenses), insurance, lab mishapps and damage due to your system malfunction to their facility (might be covered by your insurance). You also have to work out compensation scheme if your machine is damaged due to a accident or negligence form their staff.

    Comment

    • SNPsaurus
      Registered Vendor
      • May 2013
      • 525

      #3
      Most core facilities are subsidized by the university and do not need to develop a full cost accounting for the operation of their equipment. They look at prevailing rates, charge something similar, and hope the Research Office covers any loss. I'm curious what is motivating your question?
      Providing nextRAD genotyping and PacBio sequencing services. http://snpsaurus.com

      Comment

      • GenoMax
        Senior Member
        • Feb 2008
        • 7142

        #4
        Since those costs will vary from place to place even if you managed to get facilities to divulge that information it may not be of use.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 08-13-2026, 12:22 PM
        0 responses
        25 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-11-2026, 10:35 AM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-06-2026, 07:41 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-03-2026, 10:13 AM
        0 responses
        51 views
        0 reactions
        Last Post SEQadmin2  
        Working...